# A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

> **NCT00160459** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 129 (actual)

## Conditions studied

- Leiomyoma

## Interventions

- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00160459
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2001-07
- **Final completion:** 2001-07
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160459, "A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00160459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*